Topic description
DC 15 - LipAgg Doctoral Network project
The LipAgg project seeks to unravel the structural complexities of amyloid protein-lipid aggregates and investigate their role in pathological aggregation, cellular toxicity, and intercellular spread. Focusing on key human amyloid proteins —amylin (IAPP), amyloid beta (Aβ), and α-synuclein (αS)—linked to type 2 diabetes (T2D), Alzheimer's disease (AD), and Parkinson’s disease (PD), respectively, the project builds on recent discoveries made by the consortium. These findings highlight the critical role of free lipids in membrane damage through the formation of stable lipid-amyloidogenic protein complexes, leading to the lipid-chaperone hypothesis.
LipAgg Doctoral Network program
The selected PhD candidate will participate in the EU-funded HORIZON-MSCADN--01 project LipAgg. The LipAgg network brings together partners from 6 European countries and comprises 11 academic or research institutions and 12 industrial partners. The consortium is committed to delivering an outstanding training programme for 15 Doctoral Candidates (DCs) aimed at elucidating the role of lipids in the toxicity and propagation of protein aggregation.
Supervisors Prof. Gunnar Schröder
Prof. Sandrine Ongeri
Involved Company Schrödinger -
Title Lipid-Driven α-Synuclein Aggregation: Cryo-EM Structure Determination and Structure-Based Inhibitor Design
Objectives The first goal of this project is to determine the atomic structure of lipid-bound αsynuclein fibrils by cryo-EM and identify the specific lipid–protein interactions that drive membrane-mediated amyloid formation. The second goal is to exploit this structural information for the rational design and evaluation of peptide mimetics that block the lipid-binding interface, thereby inhibiting both fibril formation and associated membrane disruption.
The Position
The Doctoral candidate key tasks will be to manage and carry out the assigned research project, participate in the LipAgg training and network activities, take PhD courses, write scientific articles and your PhD thesis, participate in national and international congresses and scientific meetings, undertake a research stay at an external research laboratory within the LipAgg network, and disseminate the obtained scientific results. In particular, the DC enrolled in this position, will be working on high-resolution cryo-electron microscopy to determine the structures of lipidic alpha-synuclein (αSyn) amyloid fibrils. The aggregation of αSyn as well as its interaction with lipid membranes play a key role in Parkinson's disease. The high-resolution cryo-EM structures will show in molecular detail which αSyn-lipid interactions are responsible for driving the formation and stabilization of these amyloid fibrils. With this understanding, the DC will develop inhibitors capable of disrupting these specific αSyn-lipid interactions. This includes testing known aggregation inhibitors and using the cryo-EM structures to rationally design new peptide mimetics targeting the relevant interaction sites. This work will be performed in close collaboration with several other groups in the LipAgg network. The Doctoral Candidate (DC15) will be enrolled as PhD student at the HeinrichHeine University of Düsseldorf and will be working at the Forschungszentrum Jülich at the Ernst-Ruska-Centre (ER-C) under the supervision of Prof. Gunnar Schröder. The ER-C is Germany's national infrastructure for high-resolution electron microscopy, which is currently expanding through the ER-C 2.0 project with five globally unique next-generation instruments representing a major federal investment into electron microscopy infrastructure. The project includes a 6-month secondment in design and synthesis of peptidomimetics at the University Paris-Saclay under the supervision of Prof. Sandrine Ongeri, as well as a 3-month secondment at the company Schrödinger (tentatively in Munich). The expected start date is 1 September .
Funding category
EU funding
Funding further details
MSCA DN